GO:0042118 endothelial cell activation: Inflammatory Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042118 endothelial cell activation is defined as the change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
• Activation converts the endothelium from a quiescent, anti-adhesive barrier into a pro-adhesive, pro-inflammatory, and pro-thrombotic surface that recruits leukocytes.
• Key molecular events include VCAM-1-dependent leukocyte migration, matrix metalloproteinase activity, and loss of barrier integrity.
• The process is regulated by redox-sensitive and metabolic signaling networks, including NAD(+)-H2S signaling, sirtuin-1/AMPK, and EPAC1-dependent annexin A2 translocation.
• Dysregulated endothelial cell activation contributes to chronic inflammatory diseases, vascular aging, preeclampsia, and infection-associated vascular pathology.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in endothelial activation.
Description
Endothelial cells form the inner lining of blood vessels and normally maintain a quiescent, anti-thrombotic, and semi-permeable barrier. GO:0042118 endothelial cell activation describes the transition of these cells from a resting state to an activated state in response to cytokines, chemokines, cellular ligands, or soluble factors. This transition is central to inflammation, immunity, and vascular remodeling, and it is a major focus of research into chronic inflammatory diseases and vascular pathology. Experimental studies have shown that activated endothelial cells upregulate adhesion molecules, secrete chemokines, and remodel their cytoskeleton, thereby promoting leukocyte recruitment and altering barrier function. The activation state is not a single event but a coordinated program involving surface receptor signaling, redox changes, protease activity, and metabolic regulation. Because endothelial activation is reversible and context-dependent, it is an attractive target for pharmacological and genetic intervention. Understanding the genes and pathways that drive GO:0042118 is therefore essential for developing therapies that modulate vascular inflammation without disrupting normal barrier function.
endothelial cell activation At A Glance
| GO ID | GO:0042118 |
|---|---|
| GO term | endothelial cell activation |
| Ontology | biological_process |
| Synonym | none |
| Definition | The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. |
| Major function | Conversion of quiescent endothelium to a pro-adhesive, pro-inflammatory, and pro-thrombotic state that recruits leukocytes and alters barrier function. |
| Key stimuli | Cytokines, chemokines, cellular ligands, soluble factors, and oxidative stress such as H2O2. |
| Representative molecules | VCAM-1, MMPs, annexin A2, EPAC1, SIRT1, AMPK, and coagulation factor XI. |
| Associated diseases | Chronic inflammatory diseases, vascular aging, preeclampsia, and infection-associated vascular dysfunction. |
What Is GO:0042118?
According to the Gene Ontology, GO:0042118 endothelial cell activation is the change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. In practical terms, this means that an endothelial cell shifts from a resting, barrier-protective phenotype to an activated phenotype characterized by altered gene expression, increased adhesion molecule display, secretion of inflammatory mediators, and changes in cell shape and permeability. This definition distinguishes activation from other endothelial processes such as apoptosis or proliferation, although activated cells may subsequently undergo those fates depending on the stimulus and context.
Why Is endothelial cell activation Important in Cell Biology?
Endothelial cell activation is a central node in vascular biology because it links circulating inflammatory signals to leukocyte recruitment, barrier disruption, and thrombosis. Dysregulation of this process is implicated in chronic inflammatory diseases, vascular aging, and pregnancy-related vascular disorders such as preeclampsia. Because activation is reversible and stimulus-specific, it represents a therapeutic window for modulating inflammation without permanently damaging the endothelium. Understanding the molecular players that drive GO:0042118 is therefore critical for identifying drug targets and biomarkers in cardiovascular and inflammatory disease research.
• Drives leukocyte adhesion and transmigration during inflammation through VCAM-1-dependent mechanisms.
• Alters endothelial barrier function and permeability, contributing to edema and vascular leak.
• Is implicated in chronic inflammatory diseases such as atherosclerosis and vasculitis.
• Contributes to vascular aging through impairment of NAD(+)-H2S signaling.
• Is relevant to preeclampsia, where calcium supplementation may prevent endothelial activation.
• Can be triggered by infectious agents such as African trypanosomes.
• Involves redox-sensitive pathways, including H2O2-induced MMP activation.
• Is modulated by metabolic regulators such as SIRT1 and AMPK.
• Involves EPAC1-dependent annexin A2 translocation and plasminogen activation.
• Provides a target for pharmacological intervention in chronic inflammatory diseases.
What Happens During endothelial cell activation?
Stimulus recognition and receptor signaling
In simple terms: The endothelial cell first senses inflammatory signals through receptors on its surface.
Endothelial cell activation begins when cytokines, chemokines, cellular ligands, or soluble factors engage surface receptors on the endothelial cell. This receptor engagement triggers intracellular signaling cascades that alter gene expression and cell behavior. For example, exposure to African trypanosomes can directly activate endothelial cells, indicating that pathogens can provide activating stimuli. Oxidative stimuli such as hydrogen peroxide also activate endothelial cells and induce matrix metalloproteinase activity. The specificity of the response depends on the receptor and the downstream signaling pathway engaged.
Adhesion molecule expression and leukocyte recruitment
In simple terms: Activated endothelial cells display sticky proteins that grab passing leukocytes.
A hallmark of endothelial cell activation is the increased expression of adhesion molecules such as VCAM-1, which mediate leukocyte adhesion and migration. VCAM-1-dependent leukocyte migration requires the activation of endothelial cell-associated matrix metalloproteinases by hydrogen peroxide. This process allows leukocytes to adhere to the vessel wall and subsequently transmigrate into tissues. The upregulation of adhesion molecules is a key functional readout of endothelial activation in inflammatory diseases.
Barrier function and permeability changes
In simple terms: The normally tight blood vessel wall becomes leaky during activation.
Endothelial activation often leads to increased permeability and loss of barrier function. Coagulation factor XI has been shown to regulate endothelial cell permeability and barrier function in vitro and in vivo, linking coagulation pathways to endothelial activation. This barrier disruption contributes to edema and allows plasma proteins and immune cells to enter tissues. The regulation of barrier integrity is therefore a critical component of the activated endothelial phenotype.
Redox and metabolic regulation
In simple terms: Chemical signals inside the cell, including oxidants and metabolic sensors, control how activated the cell becomes.
Redox-sensitive pathways modulate endothelial cell activation. Hydrogen peroxide activates endothelial cell-associated MMPs, which are required for VCAM-1-dependent leukocyte migration. Ginsenoside Rb1 reduces H2O2-induced endothelial dysfunction by stimulating the sirtuin-1/AMP-activated protein kinase pathway, indicating that SIRT1 and AMPK are negative regulators of activation. Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging, linking metabolic and redox signaling to endothelial activation status. These findings suggest that metabolic and redox sensors are integral to the activation program.
Cytoskeletal and secretory remodeling
In simple terms: The cell changes its shape and releases factors that further promote inflammation.
Activated endothelial cells undergo changes in morphology, including cytoskeletal rearrangement and altered secretory activity. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation, demonstrating that intracellular trafficking and secretory events are part of the activation response. These changes facilitate processes such as angiogenesis, coagulation, and immune cell recruitment. The morphological and behavioral changes are coordinated with gene expression programs that sustain the activated state.
Key Genes Involved in GO:0042118 endothelial cell activation
The following genes and proteins have been experimentally implicated in endothelial cell activation (GO:0042118) in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VCAM-1 | Mediates leukocyte adhesion and migration | Key marker of endothelial activation; target for anti-inflammatory strategies |
| MMPs | Degrade extracellular matrix; required for VCAM-1-dependent migration | Activated by H2O2 during endothelial activation |
| F11 (factor XI) | Regulates endothelial permeability and barrier function | Links coagulation to endothelial activation |
| EPAC1 | Regulates annexin A2 surface translocation and plasminogen activation | Controls secretory and fibrinolytic responses in activated endothelium |
| ANXA2 (annexin A2) | Cell surface translocation; plasminogen activation | Effector of EPAC1 signaling in endothelial activation |
| SIRT1 | NAD+-dependent deacetylase; promotes endothelial function | Stimulated by ginsenoside Rb1 to reduce H2O2-induced dysfunction |
| AMPK | Energy sensor; promotes endothelial homeostasis | Activated in conjunction with SIRT1 to prevent endothelial activation |
| CSE (cystathionine gamma-lyase) | Produces H2S; part of NAD(+)-H2S signaling network | Impairment causes reversible vascular aging |
| eNOS | Produces nitric oxide; maintains vascular tone | Part of endothelial signaling network affected in activation |
| IL-6 | Pro-inflammatory cytokine | Can stimulate endothelial activation |
| TNF-alpha | Pro-inflammatory cytokine | Classic activator of endothelial cells |
| IL-1beta | Pro-inflammatory cytokine | Induces endothelial adhesion molecules |
| NF-kB | Transcription factor | Master regulator of inflammatory gene expression in activated endothelium |
| ICAM-1 | Adhesion molecule | Supports leukocyte firm adhesion during activation |
| E-selectin | Adhesion molecule | Mediates leukocyte rolling on activated endothelium |
| CXCL8 (IL-8) | Chemokine | Recruits neutrophils to activated endothelium |
| MCP-1 (CCL2) | Chemokine | Recruits monocytes to activated endothelium |
How Is endothelial cell activation Regulated?
Endothelial cell activation is regulated by a network of redox-sensitive and metabolic pathways. The sirtuin-1/AMP-activated protein kinase pathway acts as a negative regulator, as stimulation of this pathway by ginsenoside Rb1 reduces H2O2-induced endothelial dysfunction. The NAD(+)-H2S signaling network is also critical; its impairment leads to vascular aging, and its restoration is reversible. EPAC1 regulates annexin A2 translocation and plasminogen activation, adding another layer of control over the activated phenotype. Coagulation factor XI modulates endothelial permeability, indicating crosstalk between coagulation and activation pathways. These regulatory mechanisms provide multiple entry points for experimental intervention.
endothelial cell activation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VCAM-1 | Chronic inflammatory diseases; leukocyte recruitment | KO and overexpression in HUVECs |
| F11 | Vascular barrier dysfunction; coagulation crosstalk | KO mouse and endothelial-specific knockout |
| SIRT1 | Vascular aging; oxidative stress | Endothelial-specific KO and overexpression |
| EPAC1 | Fibrinolysis and vascular remodeling | KO and point-mutation models |
| CSE | Vascular aging; H2S signaling | KO and knock-in models |
Chronic inflammatory diseases
Endothelial cell activation is a hallmark of chronic inflammatory diseases such as atherosclerosis and vasculitis. Molecular pathways of endothelial activation are being explored for targeted pharmacological intervention in these conditions. The upregulation of adhesion molecules and chemokines on activated endothelium promotes the recruitment of inflammatory cells into the vessel wall. Targeting these pathways may reduce inflammation without compromising normal endothelial function.
Vascular aging
Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging. This suggests that endothelial cell activation status is mechanistically linked to age-related vascular dysfunction. Restoring this network may reverse aspects of vascular aging. The finding highlights the importance of metabolic and redox regulation in endothelial activation.
Preeclampsia
Calcium supplementation prevents endothelial cell activation, which may be relevant to preeclampsia. This observation links endothelial activation to the pathophysiology of preeclampsia, a pregnancy-specific hypertensive disorder. The study suggests that modulating endothelial activation could be a preventive strategy. Further research is needed to translate this finding into clinical practice.
Infection-associated vascular dysfunction
Endothelial cell activation occurs in the presence of African trypanosomes, indicating that parasitic infections can directly trigger vascular activation. This may contribute to the vascular pathology observed in trypanosomiasis. The study provides a model for understanding how pathogens activate endothelial cells. It also underscores the broad relevance of GO:0042118 beyond sterile inflammation.
From endothelial cell activation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X required for endothelial activation? | CRISPR knockout in primary endothelial cells or HUVECs |
| Does a specific mutation in gene X alter activation? | Point-mutation knock-in via CRISPR |
| Does overexpression of gene X drive activation? | CRISPR-mediated overexpression or lentiviral overexpression |
| How does gene X affect barrier function? | Endothelial-specific knockout mouse and in vitro permeability assays |
| What is the role of gene X in leukocyte recruitment? | VCAM-1-dependent migration assays with KO endothelial cells |
| Does gene X regulate redox-sensitive activation? | H2O2-stimulated endothelial cells with KO or overexpression |
How to Study the endothelial cell activation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify activation-induced transcripts |
| Proteomics | Protein abundance and modifications | Quantify adhesion molecules and secreted factors |
| Permeability assay | Endothelial barrier function | Assess barrier disruption during activation |
| Leukocyte adhesion assay | VCAM-1-dependent leukocyte binding | Measure functional activation |
| Immunofluorescence | Protein localization and morphology | Visualize cytoskeletal and trafficking changes |
| CRISPR screen | Gene requirement for activation | Identify novel regulators |
| Western blot | Protein expression and phosphorylation | Validate signaling pathways |
Transcriptomic profiling
RNA sequencing can identify global changes in gene expression during endothelial cell activation. This approach reveals upregulation of adhesion molecules, chemokines, and inflammatory pathways. Comparing activated versus quiescent endothelial cells provides a comprehensive view of the activation program. It is often used in combination with CRISPR screens to identify regulators.
Proteomic and secretome analysis
Proteomics can quantify changes in surface adhesion molecules and secreted factors during activation. For example, VCAM-1 surface expression and MMP activity are key proteomic readouts. Secretome analysis can identify chemokines and cytokines released by activated endothelium. These methods complement transcriptomic data.
Functional assays for barrier and adhesion
Endothelial permeability assays measure barrier function, which is altered during activation. Leukocyte adhesion and migration assays assess VCAM-1-dependent recruitment. These functional assays are essential for validating findings from omics studies. They can be performed in vitro with cultured endothelial cells or in vivo with animal models.
Imaging and live-cell analysis
Immunofluorescence and live-cell imaging can visualize cytoskeletal changes, adhesion molecule clustering, and annexin A2 translocation. These techniques provide spatial and temporal information about activation events. They are particularly useful for studying morphological changes. Imaging can be combined with genetic perturbations to link genes to phenotypes.
How CRISPR Can Be Used to Study GO:0042118 endothelial cell activation
Knockout
CRISPR knockout of candidate genes in endothelial cells can determine whether they are required for activation. For example, knocking out F11 can test its role in endothelial permeability. Knocking out SIRT1 or AMPK can reveal their contribution to H2O2-induced dysfunction. Knockout studies are essential for establishing causality in GO:0042118.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to test the function of individual residues. For example, mutating EPAC1 at key regulatory sites can dissect its role in annexin A2 translocation. Point mutations can also model human disease variants that affect endothelial activation. This approach provides mechanistic insight beyond simple knockout.
Knock-in
CRISPR knock-in can introduce tagged versions of proteins to track their localization and interactions. For example, knocking in a fluorescent tag on annexin A2 allows live-cell imaging of its surface translocation. Knock-in of reporter genes can also monitor activation-induced promoter activity. This technique is valuable for studying dynamic processes in endothelial activation.
Overexpression
CRISPR-mediated overexpression or lentiviral overexpression can test whether increasing a gene's activity is sufficient to induce activation. For example, overexpressing SIRT1 or AMPK may protect against H2O2-induced dysfunction. Overexpressing VCAM-1 can enhance leukocyte adhesion. Overexpression studies complement loss-of-function approaches.
How EDITGENE Supports endothelial cell activation Research
Researchers studying endothelial cell activation-related genes often need to determine whether a candidate gene is causally involved in the activation program. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in endothelial cells and animal models.
Contact EDITGENE today to design your custom CRISPR model for endothelial cell activation research.
Frequently Asked Questions About endothelial cell activation
What is endothelial cell activation?
Endothelial cell activation (GO:0042118) is the change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
What genes are involved in endothelial cell activation?
Key genes include VCAM-1, MMPs, F11, EPAC1, ANXA2, SIRT1, AMPK, and CSE, among others.
What is the GO ID for endothelial cell activation?
The Gene Ontology ID for endothelial cell activation is GO:0042118.
How is endothelial cell activation measured?
It is measured by adhesion molecule expression (e.g., VCAM-1), leukocyte adhesion assays, permeability assays, and transcriptomic profiling.
What diseases are associated with endothelial cell activation?
Chronic inflammatory diseases, vascular aging, preeclampsia, and infection-associated vascular dysfunction are associated with endothelial activation.
What role does VCAM-1 play in endothelial cell activation?
VCAM-1 mediates leukocyte adhesion and migration, and its function requires H2O2-activated MMPs.
How does oxidative stress affect endothelial cell activation?
Hydrogen peroxide activates endothelial cell-associated MMPs and can induce dysfunction, while SIRT1/AMPK activation protects against it.
Can endothelial cell activation be reversed?
Yes, impairment of NAD(+)-H2S signaling in vascular aging is reversible, and calcium supplementation may prevent activation in preeclampsia.
What models are used to study endothelial cell activation?
Primary endothelial cells, HUVECs, and endothelial-specific knockout mice are commonly used.
How can CRISPR be used to study endothelial cell activation?
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing of candidate genes in endothelial activation.
Conclusion
GO:0042118 endothelial cell activation is a fundamental biological process that underlies vascular inflammation, barrier regulation, and immune cell recruitment. Research using CRISPR-based models has identified key genes such as F11, SIRT1, AMPK, EPAC1, and VCAM-1 that control distinct aspects of the activation program. Dysregulation of this process contributes to chronic inflammatory diseases, vascular aging, preeclampsia, and infection-associated vascular pathology. Continued investigation using knockout, point-mutation, knock-in, and overexpression models will further clarify the causal mechanisms and identify therapeutic targets.
References
- 1. Puy C et al.. 2024. Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo.. Blood 144(17):1821-1833 PMID: 39158072
- 2. Cook-Mills JM. 2006. Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration.. Cell Mol Biol (Noisy-le-grand) 52(4):8-16 PMID: 17543193
- 3. Kułdo JM et al.. 2005. Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases.. Curr Vasc Pharmacol 3(1):11-39 PMID: 15638780
- 4. Girard M et al.. 2005. Endothelial cell activation in the presence of African trypanosomes.. Mol Biochem Parasitol 139(1):41-9 PMID: 15610818
- 5. Chen Q et al.. 2013. Calcium supplementation prevents endothelial cell activation: possible relevance to preeclampsia.. J Hypertens 31(9):1828-36 PMID: 23822977
- 6. Zheng Z et al.. 2020. Ginsenoside Rb1 reduces H2O2‑induced HUVEC dysfunction by stimulating the sirtuin‑1/AMP‑activated protein kinase pathway.. Mol Med Rep 22(1):247-256 PMID: 32377712
- 7. Yang W et al.. 2018. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.. FASEB J 32(4):2212-2222 PMID: 29217666
- 8. Das A et al.. 2018. Impairment of an Endothelial NAD(+)-H(2)S Signaling Network Is a Reversible Cause of Vascular Aging.. Cell 173(1):74-89.e20 PMID: 29570999
